rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
6	gastritis h pylori	C0744310	2	29	1.3091230621764538e-07	8.356545961e-06	PTGS1,PTGS2
7	Creutzfeldt-Jakob Disease, Sporadic	C1852467	2	31	1.609678889069599e-07	9.74930362117e-06	PTGS1,PTGS2
8	keratoacanthoma	C0022572	2	34	2.1417989881644672e-07	1.11420612813e-05	PTGS1,PTGS2
9	Rotavirus Infections	C0035869	2	39	3.2686680195848083e-07	1.25348189415e-05	PTGS1,PTGS2
14	Anaphylactic shock NOS	C0002792	2	43	4.4108199792614045e-07	1.94986072423e-05	PTGS1,PTGS2
15	Stomach Diseases	C0038354	2	44	4.7325519580976305e-07	2.08913649025e-05	PTGS1,PTGS2
16	Renovascular hypertension	C0020545	2	48	6.175244929851331e-07	2.22841225627e-05	PTGS1,PTGS2
17	Neuritis	C0027813	2	50	6.995171345502982e-07	2.36768802228e-05	PTGS1,PTGS2
22	Cervical Adenocarcinoma	C0279672	2	53	8.356054636005084e-07	3.06406685237e-05	PTGS1,PTGS2
23	Dyspepsia	C0013395	2	56	9.882797319393788e-07	3.20334261838e-05	PTGS1,PTGS2
24	Medullary carcinoma	C0206693	2	57	1.0430049294241073e-06	3.3426183844e-05	PTGS1,PTGS2
31	Colonic Polyps	C0009376	2	61	1.2819106172123895e-06	4.31754874652e-05	PTGS1,PTGS2
32	Esophagitis	C0014868	2	62	1.3468323855070352e-06	4.45682451253e-05	PTGS1,PTGS2
33	Idiopathic Inflammatory Myopathies	C0751356	2	62	1.3468323855070352e-06	4.59610027855e-05	PTGS1,PTGS2
34	Cytochrome-c oxidase deficiency	C0268237	2	63	1.4138633105398313e-06	4.73537604457e-05	PTGS1,PTGS2
35	gliosarcoma	C0206726	2	64	1.4831528779568615e-06	4.87465181058e-05	PTGS1,PTGS2
36	Colorectal polyposis	C0949059	2	66	1.6283519320703377e-06	5.0139275766e-05	PTGS1,PTGS2
43	Peutz-Jeghers syndrome	C0031269	2	73	2.2103440024956456e-06	5.98885793872e-05	PTGS1,PTGS2
49	Duodenal Ulcer	C0013295	2	80	2.916050420020966e-06	6.82451253482e-05	PTGS1,PTGS2
50	Adult type dermatomyositis	C0221056	2	83	3.2591871278464524e-06	6.96378830084e-05	PTGS1,PTGS2
51	Intestinal polyp	C0021846	2	84	3.379313326834499e-06	7.10306406685e-05	PTGS1,PTGS2
54	Urinary tract infection	C0042029	2	92	4.44708150404427e-06	7.5208913649e-05	PTGS1,PTGS2
60	Creutzfeldt-Jakob Syndrome	C0022336	2	95	4.898853483426002e-06	8.356545961e-05	PTGS1,PTGS2
61	Hyperplastic Polyp	C0333983	2	98	5.380040115632312e-06	8.49582172702e-05	PTGS1,PTGS2
65	Polymyositis	C0085655	2	102	6.068923338986565e-06	9.05292479109e-05	PTGS1,PTGS2
66	Intraocular pressure disorder	C0595921	2	102	6.068923338986565e-06	9.1922005571e-05	PTGS1,PTGS2
71	Hamartoma	C0018552	2	106	6.813862944876625e-06	9.88857938719e-05	PTGS1,PTGS2
72	Helicobacter Infections	C0079487	2	110	7.617025229222918e-06	0.000100278551532	PTGS1,PTGS2
77	Dermatomyositis	C0011633	2	115	8.705912078577072e-06	0.000107242339833	PTGS1,PTGS2
78	Ovarian cyst	C0029927	2	116	8.935376965668596e-06	0.000108635097493	PTGS1,PTGS2
79	Gastric ulcer	C0038358	2	116	8.935376965668596e-06	0.000110027855153	PTGS1,PTGS2
81	Peptic ulcer	C0030920	2	123	1.0654524916109409e-05	0.000112813370474	PTGS1,PTGS2
89	Musculoskeletal Diseases	C0026857	2	132	1.3168617792325144e-05	0.000123955431755	PTGS1,PTGS2
90	Pregnancy Complications, Hematologic	C0032964	2	133	1.346998074402972e-05	0.000125348189415	PTGS1,PTGS2
91	Myositis	C0027121	2	136	1.4401373011230234e-05	0.000126740947075	PTGS1,PTGS2
98	Lyme Disease	C0024198	2	140	1.5708053201390904e-05	0.000136490250696	PTGS1,PTGS2
104	Arthropathy	C0022408	2	147	1.8179009478647146e-05	0.000144846796657	PTGS1,PTGS2
105	Polycystic kidney disease, autosomal dominant	C0022680	2	147	1.8179009478647146e-05	0.000146239554318	PTGS1,PTGS2
111	Fetal Diseases	C0015929	2	151	1.9699768905034887e-05	0.000154596100279	PTGS1,PTGS2
112	Ureteral obstruction	C0041956	2	154	2.0893830297241678e-05	0.000155988857939	PTGS1,PTGS2
117	Thrombosis	C0040053	2	157	2.213472056300514e-05	0.00016295264624	PTGS1,PTGS2
128	Primary open angle glaucoma juvenile onset 1	C0339573	2	172	2.9071734873209465e-05	0.000178272980501	PTGS1,PTGS2
130	Hyperalgesia	C0020429	2	177	3.166749754823783e-05	0.000181058495822	PTGS1,PTGS2
135	Eclampsia	C0013537	2	183	3.497865172108483e-05	0.000188022284123	PTGS1,PTGS2
136	Flushing	C0016382	1	25	3.7022609550851904e-05	0.000189415041783	PTGS1
137	Fetal Membranes, Premature Rupture	C0015943	2	194	4.1626205851907905e-05	0.000190807799443	PTGS1,PTGS2
138	Chorioamnionitis	C0008495	2	195	4.226867574508297e-05	0.000192200557103	PTGS1,PTGS2
139	Connective Tissue Diseases	C0009782	2	196	4.291765964781202e-05	0.000193593314763	PTGS1,PTGS2
140	Cardiovascular morbidity	C1301700	1	27	4.329969676541978e-05	0.000194986072423	PTGS1
141	Medullary thyroid carcinoma	C0238462	2	201	4.626101451910003e-05	0.000196378830084	PTGS1,PTGS2
142	Echinococcosis	C0013502	1	28	4.662131558863525e-05	0.000197771587744	PTGS1
143	Squamous cell carcinoma of the hypopharynx	C0280321	1	28	4.662131558863525e-05	0.000199164345404	PTGS2
144	Early gastric cancer	C0349530	1	28	4.662131558863525e-05	0.000200557103064	PTGS2
145	Malignant neoplasm of vulva	C0375071	1	28	4.662131558863525e-05	0.000201949860724	PTGS2
146	Premature Obstetric Labor	C0022876	2	203	4.7644907668620284e-05	0.000203342618384	PTGS1,PTGS2
147	Arthritis, Psoriatic	C0003872	2	204	4.8346968974488647e-05	0.000204735376045	PTGS1,PTGS2
148	Bladder neck obstruction	C0005694	1	29	5.0065109443941935e-05	0.000206128133705	PTGS2
149	Aortic atherosclerosis	C0155733	1	29	5.0065109443941935e-05	0.000207520891365	PTGS2
150	Squamous Cell Neoplasms	C0206720	1	29	5.0065109443941935e-05	0.000208913649025	PTGS2
151	Aortic valve calcification	C0428791	1	30	5.363080417897237e-05	0.000210306406685	PTGS2
152	Thymic Carcinoma	C1322286	1	30	5.363080417897237e-05	0.000211699164345	PTGS2
153	Endothelial dysfunction	C0856169	2	216	5.730870397357979e-05	0.000213091922006	PTGS1,PTGS2
154	Anterior myocardial infarction	C0340293	1	33	6.505888095165169e-05	0.000214484679666	PTGS2
155	Prostatitis	C0497496	1	33	6.505888095165169e-05	0.000215877437326	PTGS2
156	Enzyme inhibition disorder	C0877008	1	33	6.505888095165169e-05	0.000217270194986	PTGS2
157	Mucinous Neoplasm	C1334811	1	33	6.505888095165169e-05	0.000218662952646	PTGS2
158	Lupus Nephritis	C0024143	2	226	6.555993781942604e-05	0.000220055710306	PTGS1,PTGS2
159	Pericardial effusion	C0031039	1	34	6.911165445966372e-05	0.000221448467967	PTGS2
160	Streptococcal pneumonia	C0155862	1	34	6.911165445966372e-05	0.000222841225627	PTGS2
161	Hepatic encephalopathy	C0019151	1	35	7.328605057499438e-05	0.000224233983287	PTGS1
162	Rhinitis, Allergic, Perennial	C0035457	1	35	7.328605057499438e-05	0.000225626740947	PTGS2
163	Osteoarthritis of distal interphalangeal joint	C0409957	1	35	7.328605057499438e-05	0.000227019498607	PTGS2
164	Nasal polyposis	C0027430	2	236	7.45556655740165e-05	0.000228412256267	PTGS1,PTGS2
165	Gastritis	C0017152	2	237	7.54973543443116e-05	0.000229805013928	PTGS1,PTGS2
166	Dermal atrophy	C0151514	2	237	7.54973543443116e-05	0.000231197771588	PTGS1,PTGS2
167	Peptic Ulcer Hemorrhage	C0041582	1	36	7.758197107710085e-05	0.000232590529248	PTGS1
168	Invasive Lobular Breast Carcinoma	C0279565	1	36	7.758197107710085e-05	0.000233983286908	PTGS2
169	Sudden death	C0011071	1	37	8.199939989705918e-05	0.000235376044568	PTGS2
170	Acute postoperative pain	C0030201	1	37	8.199939989705918e-05	0.000236768802228	PTGS2
171	Salmonella infections	C0036117	1	37	8.199939989705918e-05	0.000238161559889	PTGS2
172	Sclerosis	C0036429	1	37	8.199939989705918e-05	0.000239554317549	PTGS2
173	Osteoarthritis of the hand	C0263746	1	37	8.199939989705918e-05	0.000240947075209	PTGS2
174	Simple pneumoconiosis	C0032273	1	38	8.653814902703783e-05	0.000242339832869	PTGS2
175	Ovarian hyperstimulation syndrome	C0085083	1	38	8.653814902703783e-05	0.000243732590529	PTGS2
176	Xeroderma pigmentosum, group A	C0268135	1	38	8.653814902703783e-05	0.000245125348189	PTGS2
177	Malignant gastrointestinal tract tumors	C0685938	2	251	8.951076479368769e-05	0.00024651810585	PTGS1,PTGS2
178	Purpura, Thrombotic Thrombocytopenic	C0034155	1	39	9.119820476088947e-05	0.00024791086351	PTGS2
179	Prostate cancer stage C	C0280280	1	39	9.119820476088947e-05	0.00024930362117	PTGS2
180	Diffuse Astrocytoma	C0280785	1	39	9.119820476088947e-05	0.00025069637883	PTGS2
181	Juvenile polyposis syndrome	C0345893	1	39	9.119820476088947e-05	0.00025208913649	PTGS2
182	Gastro-esophageal reflux disease with esophagitis	C0677659	1	39	9.119820476088947e-05	0.00025348189415	PTGS2
183	Cerebral aneurysm	C0917996	1	39	9.119820476088947e-05	0.000254874651811	PTGS2
184	Gastric Cardia Adenocarcinoma	C1333762	1	39	9.119820476088947e-05	0.000256267409471	PTGS2
185	Netherton syndrome	C0265962	1	40	9.597949397144312e-05	0.000257660167131	PTGS2
186	Intestinal Cancer	C0346627	1	40	9.597949397144312e-05	0.000259052924791	PTGS2
187	Neuropathogenesis	C1518296	1	40	9.597949397144312e-05	0.000260445682451	PTGS2
188	Adenoma of large intestine	C1302401	2	257	9.600334904324992e-05	0.000261838440111	PTGS1,PTGS2
189	Bronchogenic Carcinoma	C0007121	1	41	0.0001008820307765168	0.000263231197772	PTGS2
190	Neoplasm of the tongue	C0040411	1	41	0.0001008820307765168	0.000264623955432	PTGS2
191	Experimental Organism Basal Cell Carcinoma	C3811653	2	264	0.00010395929030193596	0.000266016713092	PTGS1,PTGS2
192	Displacement of intervertebral disc	C0021818	1	42	0.00010590557092893249	0.000267409470752	PTGS2
193	Primary Sjï¿½gren's syndrome	C0205225	1	42	0.00010590557092893249	0.000268802228412	PTGS1
194	Chemical Carcinogenesis	C0596321	1	42	0.00010590557092893249	0.000270194986072	PTGS2
195	Dryness of eye	C0314719	1	43	0.00011105021506507828	0.000271587743733	PTGS2
196	AIDS Dementia Complex	C0001849	1	44	0.00011631577408433014	0.000272980501393	PTGS2
197	Monocytic leukemia	C0598894	1	44	0.00011631577408433014	0.000274373259053	PTGS2
198	Thromboangiitis Obliterans	C0040021	1	45	0.00012170223540242109	0.000275766016713	PTGS2
199	Drug usage	C0242510	1	45	0.00012170223540242109	0.000277158774373	PTGS2
200	Dry Eye Syndromes	C0013238	1	46	0.00012720943961064268	0.000278551532033	PTGS2
201	Chronic Fatigue Syndrome	C0015674	1	46	0.00012720943961064268	0.000279944289694	PTGS2
202	CARCINOMA OF VULVA	C0677055	1	46	0.00012720943961064268	0.000281337047354	PTGS2
203	polyps	C0032584	2	284	0.00012904016997627998	0.000282729805014	PTGS1,PTGS2
204	Rectal Carcinoma	C0149978	2	286	0.00013174592226750104	0.000284122562674	PTGS1,PTGS2
205	Drusen	C1260959	1	47	0.00013283745710790384	0.000285515320334	PTGS2
206	Pelvic inflammatory disease	C0242172	1	48	0.00013858616155659753	0.000286908077994	PTGS2
207	Bile duct cancer resectable	C0740277	1	48	0.00013858616155659753	0.000288300835655	PTGS2
208	Poorly differentiated carcinoma	C0741899	1	48	0.00013858616155659753	0.000289693593315	PTGS2
209	Friedreich's ataxia	C0016719	1	49	0.0001444555074693321	0.000291086350975	PTGS2
210	Pleuritis	C0032231	1	49	0.0001444555074693321	0.000292479108635	PTGS2
211	Helicobacter pylori infection	C0850666	2	297	0.00014729246954292563	0.000293871866295	PTGS1,PTGS2
212	Arthritis, Reactive	C0085435	1	50	0.000150445279389122	0.000295264623955	PTGS2
213	Idiopathic fibrosing alveolitis, chronic form	C0085786	1	50	0.000150445279389122	0.000296657381616	PTGS2
214	Hematocrit level	C0518014	1	50	0.000150445279389122	0.000298050139276	PTGS2
215	Adenocarcinoma Of Esophagus	C0279628	2	300	0.00015173102536591987	0.000299442896936	PTGS1,PTGS2
216	Bloom syndrome	C0005859	1	51	0.00015655557724270075	0.000300835654596	PTGS2
217	Uterine Cancer	C0153567	1	51	0.00015655557724270075	0.000302228412256	PTGS2
218	Reperfusion Injury	C0035126	2	305	0.0001593212308806935	0.000303621169916	PTGS1,PTGS2
219	Lupus Vulgaris	C0024131	2	307	0.00016242543836109125	0.000305013927577	PTGS1,PTGS2
220	Peptic Esophagitis	C0014869	1	52	0.0001627862729773888	0.000306406685237	PTGS2
221	Leukoplakia	C0023531	1	52	0.0001627862729773888	0.000307799442897	PTGS2
222	Squamous intraepithelial lesion	C0333873	1	52	0.0001627862729773888	0.000309192200557	PTGS2
223	Oncocytic Neoplasm	C1378050	1	53	0.00016913726443912314	0.000310584958217	PTGS2
224	Endometrial Hyperplasia	C0014173	1	54	0.00017560856638765276	0.000311977715877	PTGS2
225	Discoid lupus erythematosus	C0024138	2	319	0.0001818829308974923	0.000313370473538	PTGS1,PTGS2
226	Acute Coronary Syndrome	C0948089	2	320	0.00018356972345789924	0.000314763231198	PTGS1,PTGS2
227	Endometriosis of uterus	C0341858	1	56	0.00018891155800093706	0.000316155988858	PTGS2
228	Aicardi Goutieres syndrome 1	C0796126	1	56	0.00018891155800093706	0.000317548746518	PTGS2
229	Malignant Fibrous Histiocytoma	C0334463	1	57	0.00019574315918213792	0.000318941504178	PTGS2
230	Dysmorphic features	C0432072	1	57	0.00019574315918213792	0.000320334261838	PTGS1
231	Inflammatory pain	C0234251	1	58	0.00020269464085753697	0.000321727019499	PTGS2
232	Oropharyngeal squamous cell carcinoma	C0280313	1	58	0.00020269464085753697	0.000323119777159	PTGS2
233	Lymphangiomyomatosis	C0751674	1	58	0.00020269464085753697	0.000324512534819	PTGS2
234	Head and Neck Neoplasms	C0018671	2	333	0.00020643441164758247	0.000325905292479	PTGS1,PTGS2
235	Pulmonary hypertension, neonatal, susceptibility to	C0020542	2	333	0.00020643441164758247	0.000327298050139	PTGS1,PTGS2
236	Oral Submucous Fibrosis	C0029172	1	59	0.00020976615844836566	0.000328690807799	PTGS2
237	Desmoid tumor	C0079218	1	59	0.00020976615844836566	0.00033008356546	PTGS2
238	Carcinoma, Lobular	C0206692	1	59	0.00020976615844836566	0.00033147632312	PTGS2
239	Adenocarcinoma, Endometrioid	C1569637	1	59	0.00020976615844836566	0.00033286908078	PTGS2
240	Ischemic Cerebrovascular Accident	C3272363	2	338	0.0002156996014631707	0.00033426183844	PTGS1,PTGS2
241	Shigella Infections	C0013371	1	60	0.00021695741424831994	0.0003356545961	PTGS2
242	Sarcoidosis, Pulmonary	C0036205	1	60	0.00021695741424831994	0.00033704735376	PTGS2
243	Adverse drug events and drug allergies	C0041755	1	60	0.00021695741424831994	0.000338440111421	PTGS2
244	Idiopathic Pulmonary Fibrosis	C1800706	2	341	0.00022138664184878643	0.000339832869081	PTGS1,PTGS2
245	Xerostomia	C0043352	1	61	0.00022426844786382905	0.000341225626741	PTGS2
246	Malignant neoplasm of the central nervous system	C0348374	1	61	0.00022426844786382905	0.000342618384401	PTGS2
247	Ovarian adenocarcinoma	C0948216	1	61	0.00022426844786382905	0.000344011142061	PTGS2
248	Pancreatic intraepithelial neoplasia	C1301034	1	61	0.00022426844786382905	0.000345403899721	PTGS2
249	Cognition Disorders	C0009241	1	62	0.0002316991603680263	0.000346796657382	PTGS2
250	Turcot syndrome	C0265325	1	62	0.0002316991603680263	0.000348189415042	PTGS2
251	Systemic Inflammatory Response Syndrome	C0242966	1	63	0.0002392494503042908	0.000349582172702	PTGS1
252	Breast Fibrocystic Disease	C0016034	1	64	0.00024691936236598266	0.000350974930362	PTGS2
253	Ovarian Serous Adenocarcinoma	C1335177	1	64	0.00024691936236598266	0.000352367688022	PTGS2
254	Early-Stage Breast Carcinoma	C2986665	1	64	0.00024691936236598266	0.000353760445682	PTGS2
255	Thyroid Nodule	C0040137	1	65	0.00025470873897770474	0.000355153203343	PTGS2
256	Angiogenic Switch	C1510885	1	65	0.00025470873897770474	0.000356545961003	PTGS2
257	Aqueous Humor Disorders	C0595936	1	66	0.0002626174780610002	0.000357938718663	PTGS2
258	aggressive cancer	C2945759	1	67	0.0002706456527689083	0.000359331476323	PTGS2
259	Malformation of cortical development	C1955869	1	68	0.0002787929616050455	0.000360724233983	PTGS2
260	Preeclampsia/eclampsia 1	C0032914	2	371	0.0002837066648766484	0.000362116991643	PTGS1,PTGS2
261	Malignant neoplasm of colon stage IV	C0278484	1	69	0.0002870594771154922	0.000363509749304	PTGS2
262	Premature Birth	C0151526	2	376	0.00029508664938293627	0.000364902506964	PTGS1,PTGS2
263	Hepatitis	C0019159	2	377	0.0002973976899088848	0.000366295264624	PTGS1,PTGS2
264	Pulmonary Disease, Chronic Obstructive	C0024115	2	377	0.0002973976899088848	0.000367688022284	PTGS1,PTGS2
265	Acute Lung Injury	C0242488	1	71	0.000303949895835931	0.000369080779944	PTGS2
266	Adenomatous Polyps	C0206677	1	72	0.0003125736276599067	0.000370473537604	PTGS2
267	latent infection	C0872054	1	73	0.0003213162518758139	0.000371866295265	PTGS2
268	Experimental Autoimmune Encephalomyelitis	C0014072	2	389	0.00032605320994394393	0.000373259052925	PTGS1,PTGS2
269	Bleeding with minor or no trauma	C0019080	1	74	0.000330177725425429	0.000374651810585	PTGS1
270	Polyposis syndrome, mixed hereditary 1 (4)	C0334108	1	74	0.000330177725425429	0.000376044568245	PTGS2
271	Breast Cancer Model	C1511291	1	74	0.000330177725425429	0.000377437325905	PTGS2
272	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	2	393	0.0003359886356161246	0.000378830083565	PTGS1,PTGS2
273	Oral leukoplakia	C0023532	1	75	0.00033915794784322717	0.000380222841226	PTGS2
274	Postoperative Complications	C0032787	1	75	0.00033915794784322717	0.000381615598886	PTGS2
275	Endometrioma	C0269102	1	75	0.00033915794784322717	0.000383008356546	PTGS2
276	Complications of Diabetes Mellitus	C0342257	1	75	0.00033915794784322717	0.000384401114206	PTGS2
277	Familial adenomatous polyposis 1	C0032580	2	395	0.0003410291324329462	0.000385793871866	PTGS1,PTGS2
278	Nephrocalcinosis	C0027709	1	76	0.0003482568744612724	0.000387186629526	PTGS2
279	Ischemic stroke	C0948008	2	401	0.00035644480269947376	0.000388579387187	PTGS1,PTGS2
280	Pulmonary edema	C0034063	1	77	0.00035747443793265887	0.000389972144847	PTGS2
281	Chronic gastritis	C0085695	1	77	0.00035747443793265887	0.000391364902507	PTGS2
282	Spondylarthropathies	C0949691	1	77	0.00035747443793265887	0.000392757660167	PTGS2
283	Intestinal obstruction	C0021843	1	78	0.00036681062194965364	0.000394150417827	PTGS2
284	Salivary gland neoplasm	C0036095	1	78	0.00036681062194965364	0.000395543175487	PTGS2
285	Drug Allergy	C0013182	1	79	0.0003762652396056554	0.000396935933148	PTGS1
286	Metaplasia	C0025568	1	80	0.00038583836510885927	0.000398328690808	PTGS2
287	M5b Acute differentiated monocytic leukemia	C1318544	1	80	0.00038583836510885927	0.000399721448468	PTGS2
288	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	1	80	0.00038583836510885927	0.000401114206128	PTGS2
289	Brain Ischemia	C0007786	2	415	0.0003941563727947184	0.000402506963788	PTGS1,PTGS2
290	IMMUNE SUPPRESSION	C0021079	1	81	0.0003955297269939706	0.000403899721448	PTGS2
